Medical Policy

Tagraxofusp-erzs (Elzonris)

View Document ›

Telehealth

View Document ›

Telehome Telemonitoring for Congestive Heart Failure and/or Chronic Obstructive Pulmonary Disease

View Document ›

Temporomandibular Joint (TMJ) Dysfunction

View Document ›

Thermal Capsulorrhaphy as a Treatment of Joint Instability

View Document ›

Thermography (Thermogram)

View Document ›

Tildrakizumab-asmn (Ilumya)

View Document ›

Tocilizumab (Actemra)

View Document ›

Total Ankle Replacement

View Document ›

TPMT Testing for Thiopurine Drug Response

View Document ›

Trabectedin (Yondelis)

View Document ›

Transcatheter Aortic Valve Replacement (TAVR)

View Document ›

Transcatheter Arterial Chemoembolization

View Document ›

Transcatheter Closure Devices for Septal Defects

View Document ›

Transesophageal Endoscopic Therapies for Gastroesophageal Reflux Disease (GERD)

View Document ›

Transesophageal Endoscopic Therapies for Gastroesophageal Reflux Disease (GERD)

View Document ›

Transtympanic Micropressure Applications as a Treatment of Meniere’s Disease

View Document ›

Trastuzumab (Herceptin), Trastuzumab Biosimilars, and Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta)

View Document ›

Treatment of Abnormal Uterine Bleeding and Fibroids 2019

View Document ›

Treatment of Gaucher Disease

View Document ›

Treatment of Hereditary Amyloidosis

View Document ›

Treatment of Hereditary Angioedema (HAE)

View Document ›

Treatment of Hyperhidrosis

View Document ›

Treatment of the Prostate

View Document ›

Treatment of the Prostate

View Document ›

Tumor Markers

View Document ›

Tumor Treatment Fields (TTF)

View Document ›